Coronavirus disease 2019 (COVID-19) has had an impact on anaesthetic care around the world, especially paediatric anaesthesia. Hospitals have weighed the dangers of a rise of resource-intensive COVID-19 patients against the possible morbidity of postponing elective surgical treatments. The unknown impact of COVID-19 on perioperative risk in disease-positive increases health care provider virus exposure. To reduce anxiety and the likelihood of crying with the subsequent aerosol generation, sedative premedication is indicated. If an intravenous sedation route is not available, other options (oral or intranasal) may necessitate a careful assessment of risks and benefits. Intranasal delivery has been discouraged due to concerns of induced coughing, despite the fact that this consequence is rare. It's worth noting that bitter-tasting oral solutions containing midazolam can cause spitting, coughing, and sobbing. The common practise of using paediatric patients complicates these decisions(1). We searched the MEDLINE inhalational inductions in children who do not have intravenous access is a database for papers involving COVID-19-positive paediatric patients who received general anaesthesia. A total of eight papers satisfied the criteria for inclusion, and they described a total of 20 cases (2). Preoperative COVID-19 symptoms were noted in nine patients, and one perioperative fatality was reported. Overall, further research is needed to expand the number of patients and accurately estimate the perioperative risk
